![Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy](https://www.mdpi.com/cells/cells-09-00802/article_deploy/html/images/cells-09-00802-g001.png)
Cells | Free Full-Text | The Many Facets of CD38 in Lymphoma: From Tumor–Microenvironment Cell Interactions to Acquired Resistance to Immunotherapy
![Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab | Leukemia Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-020-0840-y/MediaObjects/41375_2020_840_Fig1_HTML.png)
Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab | Leukemia
![PDF] CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma. | Semantic Scholar PDF] CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4314fe212f09142cbdf4b8e2141b1bc761f12601/5-Figure3-1.png)
PDF] CD38 expression and complement inhibitors affect response and resistance to daratumumab therapy in myeloma. | Semantic Scholar
![Cells | Free Full-Text | Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model Cells | Free Full-Text | Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model](https://pub.mdpi-res.com/cells/cells-09-02666/article_deploy/html/images/cells-09-02666-g001.png?1607929843)
Cells | Free Full-Text | Novel Insights in Anti-CD38 Therapy Based on CD38-Receptor Expression and Function: The Multiple Myeloma Model
![Cells | Free Full-Text | CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents Cells | Free Full-Text | CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents](https://pub.mdpi-res.com/cells/cells-08-01632/article_deploy/html/images/cells-08-01632-g001.png?1577743403)
Cells | Free Full-Text | CD38 Expression by Myeloma Cells and Its Role in the Context of Bone Marrow Microenvironment: Modulation by Therapeutic Agents
![Frontiers | The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases Frontiers | The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases](https://www.frontiersin.org/files/Articles/463666/fimmu-10-01187-HTML-r1/image_m/fimmu-10-01187-g001.jpg)
Frontiers | The Multi-faceted Ecto-enzyme CD38: Roles in Immunomodulation, Cancer, Aging, and Metabolic Diseases
![The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections - ScienceDirect The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S221112471931664X-fx1.jpg)
The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections - ScienceDirect
CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricide | Haematologica
![CD38 and CD157: A long journey from activation markers to multifunctional molecules - Quarona - 2013 - Cytometry Part B: Clinical Cytometry - Wiley Online Library CD38 and CD157: A long journey from activation markers to multifunctional molecules - Quarona - 2013 - Cytometry Part B: Clinical Cytometry - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e920161a-9936-4bde-9d7b-0ca2f090ce5c/cytob21092-fig-0004-m.jpg)
CD38 and CD157: A long journey from activation markers to multifunctional molecules - Quarona - 2013 - Cytometry Part B: Clinical Cytometry - Wiley Online Library
![Co-Expression of Positive Activation Marker CD38 and Negative or Exhaustion Marker PD-1 in CD8+ T Cells | Biocompare.com Kit/Reagent Review Co-Expression of Positive Activation Marker CD38 and Negative or Exhaustion Marker PD-1 in CD8+ T Cells | Biocompare.com Kit/Reagent Review](https://media.biocompare.com/m/37/article/178287/pd-1%20&%20cd38%20co-expression.jpg)
Co-Expression of Positive Activation Marker CD38 and Negative or Exhaustion Marker PD-1 in CD8+ T Cells | Biocompare.com Kit/Reagent Review
![Postnatal expression of CD38 in astrocytes regulates synapse formation and adult social memory | The EMBO Journal Postnatal expression of CD38 in astrocytes regulates synapse formation and adult social memory | The EMBO Journal](https://www.embopress.org/cms/asset/698c3946-bd73-465b-9c64-b6f861b9069e/embj2022111247-fig-0002-m.jpg)
Postnatal expression of CD38 in astrocytes regulates synapse formation and adult social memory | The EMBO Journal
![Expanding anti-CD38 immunotherapy for lymphoid malignancies | Journal of Experimental & Clinical Cancer Research | Full Text Expanding anti-CD38 immunotherapy for lymphoid malignancies | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-022-02421-2/MediaObjects/13046_2022_2421_Fig2_HTML.png)